ECM
CLB icon

ETrade Capital Management’s Core Laboratories CLB Stock Holding History

ETrade Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30,525
Closed -$1.42M – 796
2019
Q3 		$1.42M Buy
30,525
+12,680
+71% +$590K 0.04% 264
2019
Q2 		$933K Buy
17,845
+6,271
+54% +$368K 0.03% 366
2019
Q1 		$798K Buy
+11,574
New +$776K 0.02% 391

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

ETrade Capital Management's CLB Position: Q4 2019 in Review

ETrade Capital Management sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 30,525 shares — an estimated $1.42M sold.

ETrade Capital Management first reported a position in CLB in Q1 2019 and held it in 3 quarters. The position peaked at $1.42M in Q3 2019. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • ETrade Capital Management reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
  • ETrade Capital Management sold 30,525 Core Laboratories shares in Q4 2019, an estimated $1.42M.
  • ETrade Capital Management first reported a position in Core Laboratories in Q1 2019 and held it in 3 quarters.
  • ETrade Capital Management's Core Laboratories position peaked at $1.42M in Q3 2019.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on ETrade Capital Management's 13F filing for Q4 2019, filed 7 Feb 2020.